Copyright
©The Author(s) 2020.
World J Gastroenterol. May 21, 2020; 26(19): 2333-2348
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2333
Published online May 21, 2020. doi: 10.3748/wjg.v26.i19.2333
Table 4 Therapeutic strategies
Mild gastroparesis | Moderate gastroparesis | Severe gastroparesis | |
Diet and nutritional support | Adequate oral nutrition | Disturbed oral nutrition | Compromized oral nutrition |
Small frequent meals; Low fat, low fibre; Glycemic control in diabetics | Small, frequent meals; Low fat, low fibre; Glycemic control in diabetics; Caloric liquids; Artificial nutrition rarely required | Liquid nutrient supplements; Nutrition by PEG-J | |
Prokinetics | Metroclopramide; Domperidone; Levosulpiride | Metroclopramide; Domperidone; Levosulpiride | 1Metroclopramide; Domperidone; 1Levosulpiride; 1Erytromycin; Prucalopride |
Antiemetics and symptom modulators | Rarely needed | Ondansetron | 1Ondansetron; Triciclic antidepressant; Cannabinoids |
Drug-refractory patients | |||
Endoscopic techniques | Not needed | Not needed | Botulin toxin; Transpyloric stenting; Ballon dilatation; G-POEM |
Gastric electrostimulation | Not needed | Not needed | Compassionate use |
Gastric procedures | Not needed | Not needed | Laparoscopic Pyloroplastic |
- Citation: Usai-Satta P, Bellini M, Morelli O, Geri F, Lai M, Bassotti G. Gastroparesis: New insights into an old disease. World J Gastroenterol 2020; 26(19): 2333-2348
- URL: https://www.wjgnet.com/1007-9327/full/v26/i19/2333.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i19.2333